Nathan D Wong Selected Research

Nathan D Wong Research Topics

Disease

102	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 03/2002
67	Atherosclerosis 04/2024 - 05/2003
29	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 05/2003
28	Coronary Disease (Coronary Heart Disease) 12/2022 - 03/2003
20	Hypertension (High Blood Pressure) 04/2024 - 10/2006
19	Myocardial Infarction 01/2022 - 11/2003
18	Dyslipidemias (Dyslipidemia) 02/2024 - 01/2007
18	Diabetes Mellitus 02/2023 - 09/2005
15	Type 2 Diabetes Mellitus (MODY) 09/2022 - 05/2012
13	Heart Failure 04/2024 - 02/2008
13	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 07/2006
12	Stroke (Strokes) 01/2024 - 05/2009
10	Obesity 01/2024 - 01/2007
8	Inflammation (Inflammations) 07/2021 - 01/2006
6	Hypertriglyceridemia 06/2020 - 09/2010
5	Acute Coronary Syndrome 05/2022 - 01/2019
5	Hypercholesterolemia 05/2022 - 07/2006
5	Overweight 01/2021 - 04/2011
4	Chronic Renal Insufficiency 01/2023 - 07/2015
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2022 - 04/2017
4	Death (Near-Death Experience) 01/2021 - 04/2010
4	Peripheral Arterial Disease 01/2019 - 09/2005
3	Weight Loss (Weight Reduction) 10/2023 - 04/2011
3	Hyperlipidemias (Hyperlipidemia) 02/2016 - 09/2010
3	Hypotension (Low Blood Pressure) 02/2014 - 06/2003
2	Atrial Fibrillation 04/2024 - 06/2019
2	Heart Diseases (Heart Disease) 01/2024 - 01/2023
2	COVID-19 11/2022 - 03/2020
2	Ischemic Stroke 01/2022 - 01/2015
2	Fibrosis (Cirrhosis) 01/2021 - 02/2009
2	Carotid Artery Diseases 12/2020 - 10/2014
2	Insulin Resistance 07/2020 - 11/2007
2	Atherosclerotic Plaque (Atheroma) 04/2017 - 03/2010
2	Pathologic Constriction (Stenosis) 01/2016 - 07/2010
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 06/2015 - 03/2015
2	Carotid Stenosis (Carotid Artery Stenosis) 10/2014 - 07/2014
2	Hyperglycemia 11/2013 - 01/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2007 - 08/2004
2	Chest Pain (Chest Pains) 09/2007 - 01/2007
1	Body Weight (Weight, Body) 10/2023

Drug/Important Bio-Agent (IBA)

73	CalciumIBA 04/2024 - 03/2002
39	LipidsIBA 02/2024 - 06/2003
29	oxidized low density lipoproteinIBA 04/2024 - 07/2008
29	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 03/2010
26	LDL CholesterolIBA 02/2024 - 06/2003
19	CholesterolIBA 01/2024 - 03/2005
17	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2006
14	Triglycerides (Triacylglycerol)IBA 04/2022 - 05/2003
14	HDL CholesterolIBA 01/2021 - 05/2003
13	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2003
13	C-Reactive ProteinIBA 04/2022 - 03/2005
8	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 11/2003
6	Lipoprotein(a)IBA 04/2024 - 07/2016
5	HDL LipoproteinsIBA 01/2021 - 06/2003
5	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 02/2010
4	Lipoproteins (Lipoprotein)IBA 01/2023 - 06/2003
4	eicosapentaenoic acid ethyl esterIBA 01/2023 - 06/2020
4	omega-Chloroacetophenone (Mace)IBA 01/2021 - 04/2010
4	Hemoglobins (Hemoglobin)IBA 12/2020 - 02/2014
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2017 - 02/2008
4	Adenosine Triphosphate (ATP)IBA 10/2014 - 05/2006
3	pro-brain natriuretic peptide (1-76)IBA 04/2024 - 01/2020
3	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2023 - 09/2022
3	N(3)-(chloroacetyl)-2,3-diaminopropanoic acidIBA 04/2022 - 01/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 03/2009
3	Proprotein Convertase 9IBA 01/2021 - 04/2017
3	Monoclonal AntibodiesIBA 01/2021 - 04/2017
3	Complement System Proteins (Complement)IBA 07/2020 - 03/2015
3	Ezetimibe (Zetia)FDA Link 01/2018 - 01/2015
3	Insulin (Novolin)FDA Link 11/2013 - 11/2007
3	Lisinopril (Prinivil)FDA LinkGeneric 03/2012 - 11/2003
3	Chlorthalidone (Chlortalidone)FDA LinkGeneric 03/2012 - 11/2003
3	Amlodipine (Norvasc)FDA LinkGeneric 03/2012 - 11/2003
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2022 - 09/2022
2	SodiumIBA 09/2022 - 10/2019
2	TicagrelorIBA 01/2021 - 07/2020
2	alirocumabIBA 01/2021 - 01/2019
2	Fish OilsIBA 01/2021 - 07/2020
2	HomocysteineIBA 12/2020 - 03/2010
2	Liraglutide FDA Link 12/2020 - 10/2017
2	empagliflozinIBA 07/2020 - 10/2017
2	evolocumabIBA 01/2019 - 04/2017
2	Angiotensin Receptor AntagonistsIBA 08/2017 - 01/2010
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2014 - 12/2013
2	lipoprotein cholesterolIBA 02/2014 - 10/2013
2	Interleukin-6 (Interleukin 6)IBA 12/2013 - 03/2010
2	Doxazosin (Cardura)FDA LinkGeneric 12/2012 - 11/2003
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2012 - 02/2008
2	DiureticsIBA 03/2012 - 02/2008
2	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2010 - 10/2008
2	ElementsIBA 01/2007 - 10/2006
1	semaglutideIBA 08/2023
1	AnticoagulantsIBA 01/2023
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023

Therapy/Procedure

43	Therapeutics 02/2024 - 03/2005
2	Precision Medicine 02/2024 - 02/2023
2	Glycemic Control 11/2022 - 08/2017
2	Continuity of Patient Care 03/2020 - 08/2017
1	Drug Therapy (Chemotherapy) 06/2023
1	Nutrition Therapy (Medical Nutrition Therapy) 01/2023